vs

Side-by-side financial comparison of Sunoco LP (SUN) and TENET HEALTHCARE CORP (THC). Click either name above to swap in a different company.

Sunoco LP is the larger business by last-quarter revenue ($8.6B vs $5.5B, roughly 1.6× TENET HEALTHCARE CORP). TENET HEALTHCARE CORP runs the higher net margin — 11.7% vs 1.2%, a 10.5% gap on every dollar of revenue. On growth, Sunoco LP posted the faster year-over-year revenue change (63.2% vs 9.0%). Over the past eight quarters, Sunoco LP's revenue compounded faster (25.1% CAGR vs 1.5%).

Sunoco LP is an American vehicle gasoline master limited partnership company organized under Delaware state law and headquartered in Dallas, Texas. Dating back to 1886, the company has transformed from a vertically integrated energy company to a distributor of fuels and operator of energy infrastructure. It was previously engaged in oil, natural gas exploration and production, refining, chemical manufacturing, and retail fuel sales, but divested these businesses.

Tenet Healthcare Corporation is an American for-profit multinational healthcare services company based in Dallas. Through its brands, subsidiaries, joint ventures, and partnerships including United Surgical Partners International (USPI), the company operates 65 hospitals and over 450 healthcare facilities. Tenet also runs Conifer Health Solutions, which provides healthcare support services to health systems and other clients.

SUN vs THC — Head-to-Head

Bigger by revenue
SUN
SUN
1.6× larger
SUN
$8.6B
$5.5B
THC
Growing faster (revenue YoY)
SUN
SUN
+54.2% gap
SUN
63.2%
9.0%
THC
Higher net margin
THC
THC
10.5% more per $
THC
11.7%
1.2%
SUN
Faster 2-yr revenue CAGR
SUN
SUN
Annualised
SUN
25.1%
1.5%
THC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
SUN
SUN
THC
THC
Revenue
$8.6B
$5.5B
Net Profit
$101.0M
$644.0M
Gross Margin
10.7%
Operating Margin
2.1%
15.4%
Net Margin
1.2%
11.7%
Revenue YoY
63.2%
9.0%
Net Profit YoY
-28.4%
12.6%
EPS (diluted)
$4.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SUN
SUN
THC
THC
Q4 25
$8.6B
$5.5B
Q3 25
$6.0B
$5.3B
Q2 25
$5.4B
$5.3B
Q1 25
$5.2B
$5.2B
Q4 24
$5.3B
$5.1B
Q3 24
$5.8B
$5.1B
Q2 24
$6.2B
$5.1B
Q1 24
$5.5B
$5.4B
Net Profit
SUN
SUN
THC
THC
Q4 25
$101.0M
$644.0M
Q3 25
$133.0M
$579.0M
Q2 25
$86.0M
$522.0M
Q1 25
$207.0M
$622.0M
Q4 24
$141.0M
$572.0M
Q3 24
$2.0M
$681.0M
Q2 24
$493.0M
$477.0M
Q1 24
$230.0M
$2.3B
Gross Margin
SUN
SUN
THC
THC
Q4 25
10.7%
Q3 25
10.7%
Q2 25
10.6%
Q1 25
12.6%
Q4 24
11.9%
Q3 24
7.4%
Q2 24
9.2%
Q1 24
8.8%
Operating Margin
SUN
SUN
THC
THC
Q4 25
2.1%
15.4%
Q3 25
4.2%
16.8%
Q2 25
3.8%
15.6%
Q1 25
5.7%
18.1%
Q4 24
4.5%
16.2%
Q3 24
1.9%
21.3%
Q2 24
2.4%
14.9%
Q1 24
5.4%
61.2%
Net Margin
SUN
SUN
THC
THC
Q4 25
1.2%
11.7%
Q3 25
2.2%
10.9%
Q2 25
1.6%
9.9%
Q1 25
4.0%
11.9%
Q4 24
2.7%
11.3%
Q3 24
0.0%
13.3%
Q2 24
8.0%
9.3%
Q1 24
4.2%
43.5%
EPS (diluted)
SUN
SUN
THC
THC
Q4 25
$4.22
Q3 25
$3.86
Q2 25
$3.14
Q1 25
$4.27
Q4 24
$3.79
Q3 24
$4.89
Q2 24
$2.64
Q1 24
$21.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SUN
SUN
THC
THC
Cash + ST InvestmentsLiquidity on hand
$891.0M
$2.9B
Total DebtLower is stronger
$13.4B
$13.1B
Stockholders' EquityBook value
$4.2B
Total Assets
$28.4B
$29.7B
Debt / EquityLower = less leverage
3.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SUN
SUN
THC
THC
Q4 25
$891.0M
$2.9B
Q3 25
$3.0B
Q2 25
$2.6B
Q1 25
$3.0B
Q4 24
$94.0M
$3.0B
Q3 24
$4.1B
Q2 24
$2.9B
Q1 24
$2.5B
Total Debt
SUN
SUN
THC
THC
Q4 25
$13.4B
$13.1B
Q3 25
$9.5B
$13.1B
Q2 25
$7.8B
$13.1B
Q1 25
$7.7B
$13.1B
Q4 24
$7.5B
$13.1B
Q3 24
$7.3B
$12.8B
Q2 24
$7.3B
$12.8B
Q1 24
$3.8B
$12.8B
Stockholders' Equity
SUN
SUN
THC
THC
Q4 25
$4.2B
Q3 25
$4.0B
Q2 25
$3.7B
Q1 25
$4.2B
Q4 24
$4.2B
Q3 24
$3.8B
Q2 24
$3.5B
Q1 24
$3.5B
Total Assets
SUN
SUN
THC
THC
Q4 25
$28.4B
$29.7B
Q3 25
$17.8B
$29.4B
Q2 25
$14.4B
$28.7B
Q1 25
$14.3B
$29.2B
Q4 24
$14.4B
$28.9B
Q3 24
$14.1B
$29.4B
Q2 24
$14.5B
$29.3B
Q1 24
$7.4B
$28.9B
Debt / Equity
SUN
SUN
THC
THC
Q4 25
3.10×
Q3 25
3.26×
Q2 25
3.49×
Q1 25
3.13×
Q4 24
3.14×
Q3 24
3.33×
Q2 24
3.67×
Q1 24
3.70×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SUN
SUN
THC
THC
Operating Cash FlowLast quarter
$392.0M
$731.0M
Free Cash FlowOCF − Capex
$367.0M
FCF MarginFCF / Revenue
6.6%
Capex IntensityCapex / Revenue
6.6%
Cash ConversionOCF / Net Profit
3.88×
1.14×
TTM Free Cash FlowTrailing 4 quarters
$2.5B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SUN
SUN
THC
THC
Q4 25
$392.0M
$731.0M
Q3 25
$401.0M
$1.1B
Q2 25
$243.0M
$936.0M
Q1 25
$156.0M
$815.0M
Q4 24
$123.0M
$-331.0M
Q3 24
$210.0M
$1.0B
Q2 24
$-70.0M
$747.0M
Q1 24
$286.0M
$586.0M
Free Cash Flow
SUN
SUN
THC
THC
Q4 25
$367.0M
Q3 25
$244.0M
$778.0M
Q2 25
$83.0M
$743.0M
Q1 25
$55.0M
$642.0M
Q4 24
$-661.0M
Q3 24
$109.0M
$829.0M
Q2 24
$-140.0M
$602.0M
Q1 24
$245.0M
$346.0M
FCF Margin
SUN
SUN
THC
THC
Q4 25
6.6%
Q3 25
4.0%
14.7%
Q2 25
1.5%
14.1%
Q1 25
1.1%
12.3%
Q4 24
-13.0%
Q3 24
1.9%
16.2%
Q2 24
-2.3%
11.8%
Q1 24
4.5%
6.4%
Capex Intensity
SUN
SUN
THC
THC
Q4 25
6.6%
Q3 25
2.6%
5.3%
Q2 25
3.0%
3.7%
Q1 25
2.0%
3.3%
Q4 24
6.5%
Q3 24
1.8%
4.2%
Q2 24
1.1%
2.8%
Q1 24
0.7%
4.5%
Cash Conversion
SUN
SUN
THC
THC
Q4 25
3.88×
1.14×
Q3 25
3.02×
1.83×
Q2 25
2.83×
1.79×
Q1 25
0.75×
1.31×
Q4 24
0.87×
-0.58×
Q3 24
105.00×
1.53×
Q2 24
-0.14×
1.57×
Q1 24
1.24×
0.25×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SUN
SUN

Fuel Distribution$8.2B95%
Service Revenue$440.0M5%
Lease Revenue$40.0M0%
Lease Income$12.0M0%

THC
THC

Other$2.9B52%
Health Care Patient Service$1.4B25%
Equity Method Investment Nonconsolidated Investee Or Group Of Investees$1.2B22%
Health Care Other Sources$56.0M1%

Related Comparisons